NCT03587636View on ClinicalTrials.gov

Liposome Bupivacaine Interscalene Total Shoulder

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

March 15, 2021

Study Completion Date

March 17, 2021

Conditions
Acute Pain
Interventions
DRUG

liposome bupivacaine

interscalene block with liposomal bupivacaine plus bupivacaine

DRUG

Bupivacaine

interscalene block with bupivacaine

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03587636 - Liposome Bupivacaine Interscalene Total Shoulder | Biotech Hunter | Biotech Hunter